• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药治疗骨质疏松症患者骨折发生率降低:一项全国基于人群的队列研究。

Decreased fracture incidence with traditional Chinese medicine therapy in patients with osteoporosis: a nationwide population-based cohort study.

机构信息

Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan.

Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.

出版信息

BMC Complement Altern Med. 2019 Feb 4;19(1):42. doi: 10.1186/s12906-019-2446-3.

DOI:10.1186/s12906-019-2446-3
PMID:30717733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360787/
Abstract

BACKGROUND

There are no published studies regarding the efficacy of traditional Chinese medicine (TCM) for the prevention of osteoporotic fracture. Therefore, we conducted this nationwide, population-based cohort study to investigate the probable effect of TCM to decrease the fracture rate.

METHODS

We identified cases with osteoporosis and selected a comparison group that was frequency-matched according to sex, age (per 5 years), diagnosis year of osteoporosis, and index year. The difference between the two groups in the development of fracture was estimated using the Kaplan-Meier method and the log-rank test.

RESULTS

After inserting age, gender, urbanization level, and comorbidities into the Cox's proportional hazard model, patients who used TCM had a lower hazard ratio (HR) of fracture (adjusted HR: 0.47, 95% CI: 0.37-0.59) compared to the non-TCM user group. The Kaplan-Meier curves showed that osteoporosis patients who used TCM had a lower incidence of fracture events than those who did not (p < 0.00001). Our study also demonstrated that the longer the TCM use, the lesser the fracture rate.

CONCLUSION

Our study showed that TCM might have a positive impact on the prevention of osteoporotic fracture.

摘要

背景

目前尚无关于中医药预防骨质疏松性骨折疗效的研究。因此,我们进行了这项全国性、基于人群的队列研究,以探讨中医药预防骨折的可能效果。

方法

我们确定了患有骨质疏松症的病例,并选择了一个根据性别、年龄(每 5 年)、骨质疏松症诊断年份和指数年份进行频率匹配的对照组。使用 Kaplan-Meier 方法和对数秩检验估计两组之间骨折发展的差异。

结果

在将年龄、性别、城市化水平和合并症纳入 Cox 比例风险模型后,与非中医药使用者相比,使用中医药的患者骨折的风险比(调整后的 HR:0.47,95%CI:0.37-0.59)较低。Kaplan-Meier 曲线表明,使用中医药的骨质疏松症患者的骨折事件发生率低于未使用中医药的患者(p<0.00001)。我们的研究还表明,中医药使用时间越长,骨折发生率越低。

结论

我们的研究表明,中医药可能对预防骨质疏松性骨折有积极影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/6360787/439ac978ba8d/12906_2019_2446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/6360787/441851de837a/12906_2019_2446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/6360787/439ac978ba8d/12906_2019_2446_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/6360787/441851de837a/12906_2019_2446_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc00/6360787/439ac978ba8d/12906_2019_2446_Fig2_HTML.jpg

相似文献

1
Decreased fracture incidence with traditional Chinese medicine therapy in patients with osteoporosis: a nationwide population-based cohort study.中医药治疗骨质疏松症患者骨折发生率降低:一项全国基于人群的队列研究。
BMC Complement Altern Med. 2019 Feb 4;19(1):42. doi: 10.1186/s12906-019-2446-3.
2
Association of use of Chinese herbal medicines and the risk of fracture in patients with osteoporosis: a population-based cohort study.中药使用与骨质疏松症患者骨折风险的关联:基于人群的队列研究。
Osteoporos Int. 2019 Apr;30(4):807-815. doi: 10.1007/s00198-018-4789-x. Epub 2019 Feb 5.
3
Effects of combined traditional Chinese medicine therapy in patients of lower limbs injuries with osteoporosis: A retrospective paired cohort study.中药联合疗法对下肢损伤合并骨质疏松症患者的影响:一项回顾性配对队列研究。
Medicine (Baltimore). 2023 Dec 8;102(49):e36489. doi: 10.1097/MD.0000000000036489.
4
Utilization of Chinese herbal medicine and its association with the risk of fracture in patients with Parkinson's disease in Taiwan.台湾地区帕金森病患者中草药使用情况及其与骨折风险的关联。
J Ethnopharmacol. 2018 Nov 15;226:168-175. doi: 10.1016/j.jep.2018.08.021. Epub 2018 Aug 15.
5
Prescription patterns of Chinese herbal products for patients with fractures in Taiwan: A nationwide population-based study.台湾骨折患者的中草药产品处方模式:一项基于全国人口的研究。
J Ethnopharmacol. 2015 Sep 15;173:11-9. doi: 10.1016/j.jep.2015.07.014. Epub 2015 Jul 14.
6
The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosis.中药在糖尿病合并骨质疏松症患者骨折手术、住院和全因死亡率风险中的作用。
PLoS One. 2024 May 2;19(5):e0289455. doi: 10.1371/journal.pone.0289455. eCollection 2024.
7
Effect assessment of traditional Chinese medicine, Guilu Erxian Jiao, in patients with osteoporosis: A case-control study of the Chang gung memorial hospital.中药龟鹿二仙胶治疗骨质疏松症患者的效果评估:长庚纪念医院的病例对照研究。
Explore (NY). 2024 Sep-Oct;20(5):102978. doi: 10.1016/j.explore.2024.01.004. Epub 2024 Jan 14.
8
Long-term persistence with anti-osteoporosis drugs after fracture.骨折后长期坚持使用抗骨质疏松药物。
Osteoporos Int. 2015 Jun;26(6):1831-40. doi: 10.1007/s00198-015-3084-3. Epub 2015 Mar 31.
9
Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.结核病患者发生骨质疏松症和骨质疏松性骨折的风险增加:结核病流行地区的一项基于人群的研究。
Osteoporos Int. 2017 May;28(5):1711-1721. doi: 10.1007/s00198-017-3939-x. Epub 2017 Mar 22.
10
A national study on long-term osteoporosis therapy and risk of recurrent fractures in patients with hip fracture.一项关于髋部骨折患者长期骨质疏松症治疗与再发骨折风险的全国性研究。
Arch Gerontol Geriatr. 2020 May-Jun;88:104021. doi: 10.1016/j.archger.2020.104021. Epub 2020 Feb 1.

引用本文的文献

1
Association between RBC folate and lumbar bone mineral density in postmenopausal women, a cross-sectional study from NHANES 2009-2018.绝经后女性红细胞叶酸与腰椎骨密度之间的关联:一项基于2009 - 2018年美国国家健康与营养检查调查(NHANES)的横断面研究
Front Endocrinol (Lausanne). 2025 Apr 28;16:1559043. doi: 10.3389/fendo.2025.1559043. eCollection 2025.
2
Toxicokinetics of a Single Oral Dose of Aflatoxin B in Plasma, Feces, and Urine of Male Donkeys.雄性驴单次口服黄曲霉毒素B后在血浆、粪便和尿液中的毒代动力学
Toxins (Basel). 2025 Apr 20;17(4):206. doi: 10.3390/toxins17040206.
3
Effects of traditional Chinese medicine Zuo-Gui-Wan on gut microbiota in an osteoporotic mouse model.

本文引用的文献

1
Plastrum Testudinis Extracts Promote BMSC Proliferation and Osteogenic Differentiation by Regulating Let-7f-5p and the TNFR2/PI3K/AKT Signaling Pathway.龟甲提取物通过调控Let-7f-5p及TNFR2/PI3K/AKT信号通路促进骨髓间充质干细胞增殖和成骨分化。
Cell Physiol Biochem. 2018;47(6):2307-2318. doi: 10.1159/000491541. Epub 2018 Jul 5.
2
Du-Zhong (Eucommia ulmoides Oliv.) Cortex Extract Alleviates Lead Acetate-Induced Bone Loss in Rats.杜仲(Eucommia ulmoides Oliv.)树皮提取物可缓解醋酸铅致大鼠骨丢失。
Biol Trace Elem Res. 2019 Jan;187(1):172-180. doi: 10.1007/s12011-018-1362-6. Epub 2018 May 9.
3
Anti-osteoporosis activity of a novel Achyranthes bidentata polysaccharide via stimulating bone formation.
中药左归丸对骨质疏松小鼠模型肠道微生物群的影响。
J Orthop Surg Res. 2025 Feb 1;20(1):128. doi: 10.1186/s13018-025-05504-w.
4
Molecular mechanism of resveratrol promoting differentiation of preosteoblastic MC3T3-E1 cells based on network pharmacology and experimental validation.基于网络药理学和实验验证的白藜芦醇促进前成骨细胞 MC3T3-E1 细胞分化的分子机制。
BMC Complement Med Ther. 2024 Feb 29;24(1):108. doi: 10.1186/s12906-024-04396-3.
5
Efficacy and safety of oral traditional Chinese medicine combined with conventional anti-osteoporosis drugs for osteoporosis and fractures: A meta-analysis of randomized controlled trials.口服中药联合常规抗骨质疏松药物治疗骨质疏松症及骨折的疗效和安全性:一项随机对照试验的荟萃分析。
Medicine (Baltimore). 2023 Dec 22;102(51):e36634. doi: 10.1097/MD.0000000000036634.
6
The effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised rats.阿胶对去卵巢大鼠体成分、骨髓脂肪含量和骨骼氧化还原状态的影响。
Int J Med Sci. 2023 Oct 9;20(13):1711-1721. doi: 10.7150/ijms.84604. eCollection 2023.
7
Manual Reduction and Plaster External Fixation for the Treatment of Closed Total Talus Dislocation: Case Report and Literature Review.手法复位石膏外固定治疗闭合性距骨全脱位:病例报告及文献复习。
Orthop Surg. 2023 Apr;15(4):1179-1186. doi: 10.1111/os.13675. Epub 2023 Feb 7.
8
Deciphering the protective effect of Buzhong Yiqi Decoction on osteoporotic fracture through network pharmacology and experimental validation.通过网络药理学和实验验证解析补中益气汤对骨质疏松性骨折的保护作用。
J Orthop Surg Res. 2023 Feb 4;18(1):86. doi: 10.1186/s13018-023-03545-7.
9
Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.金天格联合阿法骨化醇改善原发性骨质疏松症患者的肌肉力量和平衡:一项随机、双盲、双模拟、阳性对照、多中心临床试验。
J Orthop Translat. 2022 Aug 24;35:53-61. doi: 10.1016/j.jot.2022.05.002. eCollection 2022 Jul.
10
Network Pharmacology Integrated with Molecular Docking Explores the Mechanisms of Naringin against Osteoporotic Fracture by Regulating Oxidative Stress.网络药理学结合分子对接技术探讨柚皮苷通过调节氧化应激抗骨质疏松性骨折的机制
Evid Based Complement Alternat Med. 2021 Sep 20;2021:6421122. doi: 10.1155/2021/6421122. eCollection 2021.
新型牛膝多糖通过刺激骨形成发挥抗骨质疏松活性。
Carbohydr Polym. 2018 Mar 15;184:288-298. doi: 10.1016/j.carbpol.2017.12.070. Epub 2017 Dec 30.
4
Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling.牛膝多糖通过抑制 RANKL 信号通路抑制破骨细胞分化和骨吸收。
J Cell Biochem. 2018 Jun;119(6):4826-4835. doi: 10.1002/jcb.26682. Epub 2018 Mar 9.
5
Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine.龟板提取物对阿仑膦酸钠防治糖皮质激素性大鼠脊柱骨质疏松的增效作用
Sci Rep. 2017 Sep 6;7(1):10617. doi: 10.1038/s41598-017-10614-5.
6
Total Flavonoids of Drynariae Rhizoma Prevent Bone Loss Induced by Hindlimb Unloading in Rats.骨碎补总黄酮预防大鼠去负荷性骨丢失。
Molecules. 2017 Jun 22;22(7):1033. doi: 10.3390/molecules22071033.
7
Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro.骨碎补总黄酮在体内和体外对预防骨质流失的作用。
Bone Rep. 2016 Sep 10;5:262-273. doi: 10.1016/j.bonr.2016.09.001. eCollection 2016 Dec.
8
Du-Huo-Ji-Sheng-Tang and its active component Ligusticum chuanxiong promote osteogenic differentiation and decrease the aging process of human mesenchymal stem cells.独活寄生汤及其活性成分川芎促进人间充质干细胞的成骨分化并延缓其衰老进程。
J Ethnopharmacol. 2017 Feb 23;198:64-72. doi: 10.1016/j.jep.2016.12.011. Epub 2016 Dec 28.
9
Discovery of a New Class of Cathepsin K Inhibitors in Rhizoma Drynariae as Potential Candidates for the Treatment of Osteoporosis.骨碎补中新型组织蛋白酶K抑制剂的发现:作为治疗骨质疏松症的潜在候选药物
Int J Mol Sci. 2016 Dec 16;17(12):2116. doi: 10.3390/ijms17122116.
10
Asperosaponin VI promotes bone marrow stromal cell osteogenic differentiation through the PI3K/AKT signaling pathway in an osteoporosis model.阿萨皂素 VI 通过骨质疏松症模型中的 PI3K/AKT 信号通路促进骨髓基质细胞成骨分化。
Sci Rep. 2016 Oct 19;6:35233. doi: 10.1038/srep35233.